PT  - JOURNAL ARTICLE
AU  - William R. Milligan
AU  - Zachary L. Fuller
AU  - Ipsita Agarwal
AU  - Michael B. Eisen
AU  - Molly Przeworski
AU  - Guy Sella
TI  - Impact of essential workers in the context of social distancing for epidemic control
AID  - 10.1101/2020.05.05.20092262
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.05.20092262
4099  - http://medrxiv.org/content/early/2020/05/09/2020.05.05.20092262.short
4100  - http://medrxiv.org/content/early/2020/05/09/2020.05.05.20092262.full
AB  - Many governments have responded to the ongoing COVID-19 pandemic by imposing social policies that restrict interactions outside of the home, resulting in a large fraction of the workforce either working from home or not working. However, to maintain essential services, a substantial number of workers are not subject to these limitations, and maintain many of their pre-intervention interactions. To explore how interactions among such “essential” workers, and between essential workers and the rest of the population, impact disease risk and the effectiveness of pandemic control, we evaluated several models of essential worker interactions within a standard epidemiology framework. The models were designed to correspond to key characteristics of, respectively, cashiers, factory employees, and healthcare workers. We find in all three models that essential workers are at substantially elevated risk of infection compared to the rest of the population, and that increasing the numbers of essential workers necessitates the imposition of more stringent interaction controls on the rest of the population in order to manage the pandemic. However, different archetypes of essential workers differ in both their individual probability of infection and impact on the broader pandemic, highlighting the need to understand and target for intervention the specific risks faced by different groups of essential workers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesA computational notebook is freely available to reproduce all figures and analyses in the text https://github.com/zfuller5280/Covid-19_Modeling